Literature DB >> 21337155

Epidemiology of meningococcal disease in north america.

A J Pollard1, D Scheifele, N Rosenstein.   

Abstract

Invasive disease caused by Neisseria meningitidis is one of the leading infectious causes of death in childhood in North America (1), but its prevention has not received the same priority on the health agenda as in Europe, Australia, and New Zealand. There are several likely explanations, but the principal one is that disease incidence appears to be lower in both Canada (2) and the United States (3) than in some of these other countries (4,5). Here, we describe recent epidemiological data concerning meningococcal infection in Canada and the United States and comment on the possible future introduction of vaccination to prevent meningococcal disease across the continent.

Entities:  

Year:  2001        PMID: 21337155     DOI: 10.1385/1-59259-149-3:341

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  3 in total

1.  PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z.

Authors:  Désirée E Bennett; Robert M Mulhall; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Molecular analysis of monoclonal antibodies to group variant capsular polysaccharide of Neisseria meningitidis: recurrent heavy chains and alternative light chain partners.

Authors:  Jody D Berry; Darren J Boese; Dennis K S Law; Wendell D Zollinger; Raymond S W Tsang
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

3.  The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.

Authors:  Rodica Gilca; Geneviève Deceuninck; Brigitte Lefebvre; Raymond Tsang; Rachid Amini; Vladimir Gilca; Monique Douville-Fradet; France Markowski; Philippe De Wals
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.